Cross-linked Sodium Hyaluronate Gel with PLLA-b-PEG Microspheres
The product is indicated for implantation into the deep dermis, superficial and deep subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds.
Class III Medical Device
Cross-linked Sodium Hyaluronate, PLLA-b-PEG Microspheres, Lidocaine Hydrochloride, Phosphate Buffering System
0.5 mL, 0.75 mL, 1.0 mL, 1.5 mL, 2.0 mL, 2 × 0.5 mL, 2 × 0.75 mL, 2 × 1.0 mL
This dermal filler is injected into the deep dermis, superficial and deep subcutis for the correction of facial folds and wrinkles The incorporated PLLA-b-PEG Microspheres help prolong the filling effect.
For most patients, an improvement of >1 point on the Wrinkle Severity Rating Scale (WSRS) is maintained at 12 months post-treatment.
Consultation and Purchase
